March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
The Effects Of Mitomycin, Rapamycin And Bevacizumab On Corneal Haze After Photorefractive Keratectomy
Author Affiliations & Notes
  • Hungwon Tchah
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Kyoung Sub Lee
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Mi Hyun Cheon
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Dong Ah Ko
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Jae Yong Kim
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Myoung joon Kim
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Eun-soon Kim
    Department of Ophthalmology, Asan Medical Center, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  Hungwon Tchah, None; Kyoung Sub Lee, None; Mi Hyun Cheon, None; Dong Ah Ko, None; Jae Yong Kim, None; Myoung joon Kim, None; Eun-soon Kim, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1470. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hungwon Tchah, Kyoung Sub Lee, Mi Hyun Cheon, Dong Ah Ko, Jae Yong Kim, Myoung joon Kim, Eun-soon Kim; The Effects Of Mitomycin, Rapamycin And Bevacizumab On Corneal Haze After Photorefractive Keratectomy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1470.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the effects of mitomycin, rapamycin and bevacizumab on the corneal haze and the number of keratocytes after photorefractive keratectomy(PRK)

Methods: : PRK(3mm optica zone, 80μm depth) was done in one eye of Sprague-Dawly rats(n=12). 0.02% mitomycin (M group,n=3), 2.5% bevacizumab (B group,n=3), 0.01% rapamycin (R group,n=3), and BSS (control group,n=3) were applied respectively for 2 minutes just after PRK. Then operated eyes were exposed to UV-B(100mj/cm2) light foror 2 minutes at 3 weeks after PRK. Corneal haze was assessed up to 12 weeks after PRK. H&E stain and TUNEL stain were done at 3,6,12 weeks

Results: : A single intraoperative application of bevacizumab and rapamycin immediately after PRK induced opacity and apoptosis of keratocytes.Corneal haze was less severe in treated groups compared with control group. Twelve weeks after PRK, bevacizumab and rapamycin reduced corneal haze , the number of keratocytes, apoptotic cells similar with MMC, even after UV-B irradiation.(Corneal haze score :1±0 in M group, 1±1.0 in B group, 1±1.0 in R group, and 1.8±0.8 in control group at postop 12 weeks.) Apoptosis of keratocyte was detected in all 4 groups but relatively large numbers of apoptotic cells were found only in control group even after 12 weeks. Three weeks after PRK, dying stromal cells showed cell shrinkage, and chromatin condensation was observed in all treated groups by electron microscopy. Twelve weeks after PRK, fewer keratocytes and inflammatory cells were observed just beneath the epithelial layer in Group M,B and R than control group.

Conclusions: : Bevacizumab and rapamycin is a potent inhibitor of corneal haze induced by PRK. It seems that bevacizumab and rapamycin were less toxic than mitomycin.

Keywords: refractive surgery: PRK • cornea: stroma and keratocytes • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×